Professor, Pediatric Drug Development
Dr. Klaus Rose is Managing Director of klausrose Consulting, Basel, Switzerland, since March 2011. Qualified 1986 in medicine in Berlin after studying Latin languages and psychology. Completed postgraduate clinical training in General Medicine in Germany and England and joined pharmaceutical industry in 1991. Various positions in R&D and medical affairs of progressive responsibility culminating in the position of Global Head Pediatrics at Novartis in 2002 - 2005 and then Global Head Pediatrics at Roche 2005 - 2009. From 2010 until mid March 2011 he was Principal Consultant with Granzer Regulatory Affairs, Munich, Germany. Klaus Rose is a frequent speaker on international conferences on pediatric drug development and publishes on this theme on a regular base. The second edition of “Guide to Paediatric Drug Development and Clinical Research“, which he edited together with Professor John van den Anker, was released May 2010.
Paediatric Drug Development